PubRank

Florence Apparailly

Author PubWeight™ 46.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003 4.43
2 Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 2007 2.54
3 Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum 2005 2.13
4 miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. PLoS One 2009 1.84
5 Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res Ther 2005 1.37
6 Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes. Arthritis Res Ther 2007 1.32
7 Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells. Transplantation 2006 1.29
8 Targeting monocytes/macrophages in the treatment of rheumatoid arthritis. Rheumatology (Oxford) 2012 1.23
9 Short-term BMP-2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal stem cells. Stem Cells 2004 1.23
10 What do microRNAs mean for rheumatoid arthritis? Arthritis Rheum 2012 1.21
11 Animal models for arthritis: innovative tools for prevention and treatment. Ann Rheum Dis 2011 1.20
12 Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system. Mol Ther 2004 1.17
13 Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis. Arthritis Rheum 2006 1.14
14 Immunomodulatory dendritic cells inhibit Th1 responses and arthritis via different mechanisms. J Immunol 2007 1.09
15 Immature dendritic cells suppress collagen-induced arthritis by in vivo expansion of CD49b+ regulatory T cells. J Immunol 2006 1.09
16 Glucocorticoid-induced leucine zipper is an endogenous antiinflammatory mediator in arthritis. Arthritis Rheum 2010 1.08
17 Antigen-specific immunomodulation of collagen-induced arthritis with tumor necrosis factor-stimulated dendritic cells. Arthritis Rheum 2004 1.04
18 Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes. Arthritis Rheum 2008 0.99
19 In vivo RNAi-mediated silencing of TAK1 decreases inflammatory Th1 and Th17 cells through targeting of myeloid cells. Blood 2010 0.98
20 Tetracycline-inducible viral interleukin-10 intraocular gene transfer, using adeno-associated virus in experimental autoimmune uveoretinitis. Hum Gene Ther 2005 0.97
21 Impact of microRNAs on the understanding and treatment of rheumatoid arthritis. Curr Opin Rheumatol 2013 0.95
22 Micro-CT combined with bioluminescence imaging: a dynamic approach to detect early tumor-bone interaction in a tumor osteolysis murine model. Bone 2006 0.95
23 From stem cells to bone: phenotype acquisition, stabilization, and tissue engineering in animal models. ILAR J 2009 0.95
24 Transient down-regulation of cbfa1/Runx2 by RNA interference in murine C3H10T1/2 mesenchymal stromal cells delays in vitro and in vivo osteogenesis, but does not overtly affect chondrogenesis. Exp Cell Res 2008 0.91
25 Antitumoral activity and osteogenic potential of mesenchymal stem cells expressing the urokinase-type plasminogen antagonist amino-terminal fragment in a murine model of osteolytic tumor. Stem Cells 2008 0.90
26 MicroRNAs as new player in rheumatoid arthritis. Joint Bone Spine 2011 0.88
27 Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: application to interleukin 10 therapy in experimental arthritis. Hum Gene Ther 2002 0.88
28 Concerted stimuli regulating osteo-chondral differentiation from stem cells: phenotype acquisition regulated by microRNAs. Acta Pharmacol Sin 2009 0.88
29 Adeno-associated virus-mediated IL-10 gene transfer suppresses lacrimal gland immunopathology in a rabbit model of autoimmune dacryoadenitis. Invest Ophthalmol Vis Sci 2010 0.87
30 Nicotinamide phosphoribosyltransferase/visfatin expression by inflammatory monocytes mediates arthritis pathogenesis. Ann Rheum Dis 2013 0.86
31 RNA interference-based gene therapy for successful treatment of rheumatoid arthritis. Expert Opin Biol Ther 2009 0.84
32 Adeno-associated virus type 5-mediated intraarticular administration of tumor necrosis factor small interfering RNA improves collagen-induced arthritis. Arthritis Rheum 2010 0.84
33 Prospects for gene therapy in inflammatory arthritis. Best Pract Res Clin Rheumatol 2010 0.84
34 Gene therapy for rheumatoid arthritis: current status and future prospects. BioDrugs 2011 0.84
35 Deregulation and therapeutic potential of microRNAs in arthritic diseases. Nat Rev Rheumatol 2016 0.83
36 miRNAs and rheumatoid arthritis - promising novel biomarkers. Swiss Med Wkly 2011 0.83
37 Mesenchymal stem cells and rheumatoid arthritis. Joint Bone Spine 2003 0.82
38 Transcriptomic network support distinct roles of classical and non-classical monocytes in human. Int Rev Immunol 2014 0.81
39 Cationic liposome formulations for RNAi-based validation of therapeutic targets in rheumatoid arthritis. Curr Opin Mol Ther 2010 0.77
40 Quantitative imaging of cartilage and bone for functional assessment of gene therapy approaches in experimental arthritis. J Tissue Eng Regen Med 2010 0.77
41 Looking for microRNA polymorphisms as new rheumatoid arthritis risk loci? Joint Bone Spine 2010 0.75
42 RNAi in arthritis: prospects of a future antisense therapy in inflammation. Curr Opin Mol Ther 2007 0.75